486
2435581226014562118176
Ces36957936014570127174
Urol38947936014578115180208
2021;41277936014562121178233249
25(4):44017936014562122153209240262
236–24346887936014562122182245300357415
PŘEHLEDOVÝ3675207016974156235334409485586692777867
ČLÁNEK4580207016989163260360438521
35.624896013357111133
Carlsson,781896013372126162188231275336398421
SV,1226896013363126142
Vickers139289601337097147198253289334
AJ,1750896013376121142
Lilja191689601336186112138192
H,2132896013380104
et2260896013364101
al.238589601336187110
Can2519898013172123182
one2725898013168127181
blood293189801317093152212274
draw3229898013169101152231
replace348589801314193154178227277329
transrectal383889801314375126185225257309360397447470
ultrasonography­433389801316790123156207247307366425487519570630690737769
‑estimated624104801313388128163185274323355406466
prostate1114104801316193149189224273306357
volume14951048013149106130186275329
to1848104801313490
predict1962104801316092144204226274311
prostate2297104801316092149189223273305356
cancer2677104801314999157205256288
risk?298910480131325594139179
BJU3192104801315692160
Int3376104801312381113
2013;35131048013154105153197213
112:3750104801315495139157
602–60939311048013154108157209266320373
36.6241196013356112134
Catalona,7821196013370123158211237297358410433
WJ,123811960133100134156
Partin14171196013365116152191216276
AW,17161196013374162180
Sanda19191196013361114174236289
MG,22311196013395165189
et2444119601336198
al.2565119601335985107
A26961198013171
multicenter27911198013197154176209231280330388420471503
study3318119801314782139199247
of3589119801316594
[-2]pro‑prostate3707119801313666112137196228285320381413469509544593626677
specific44081198013147106160210232258284333
antigen47651198013156114146168227280338
combined6241348013149105195254277334387448
with10961348013178100133192
prostate1312134801315991147187222271304355
specific1691134801313998152202223249276324
antigen20401348013148106137159219271329
and23931348013149106166
free2583134801312760112165
prostate2773134801315991147187222271303354
specific3151134801314099153203224250277325
antigen35001348013149106138160219272330
for3854134801312785117
prostate3995134801315991147187222271304355
cancer4374134801314797155203254285
detection46841348013158111144195244280302360419
in624149801312381
the729149801313492145
28981498013154
09691498013153
to1047149801313389
1011611498013153100
012791498013153
ng/ml13561498013154114153239262
prostate1642149801316092149189224273305356
specific20221498013141101155204226252278327
antigen23731498013150108139162221274331
range2728149801313383141200253
J30221498013138
Urol30841498013169100156179
2011;32881498013153105152193204
185:35161498013153100151166
165037061498013154101152203
37.6241646013356109120
Parekh,7671646013366117152207258320343
DJ,11331646013380117138
Punnen12951646013365124185245300361
S16791646013361
Sjoberg1764164601336186146208264299360
DD,21471646013381154173
et2343164601336299
al.2465164601336086108
A25961648013172
Multi‑institutional26921648013192150172205227260284341381415437471528562584642700749771
prospective34871648013168100157197256310359396418467519
trial403016480131417395144166
in4220164801313088
the4332164801314199152
USA45081648013176124186
confirms47181648013156112171196223254344383
that624179801313492141173
the821179801313492145
49901798013154
K10681798013150
score1142179801314190146178229
accurately1395179801315099145203234284316367390438
identifies1857179801312382135193224246272299352392
men22731798013190143201
with24981798013180102136194
high‑grade2716179801315980139197231293324374433486
prostate3226179801316193149189224274306357
cancer3607179801314999156205256287
Eur39321798013152107138
Urol40941798013169100157180
2015;42981798013153105153197212
68:45341798013154108125
464–47046831798013154109165221278326376
38.6241946013356112135
Nordstrom7821946013376137173234277314349409500
T,1306194601335874
Vickers1403194601336592141191245280324
A,1751194601337195
Assel18701946013371115158213239
M,21321946013392116
et2272194601335995
al.2390194601335782105
Comparison25191948013167123212272322353376415473532
Between30751948013159113146227279333391
the3490194801313896149
Four‑kallikrein36631948013155112170201230277328350371393438472523545602
Panel42901948013159107165218240
and45541948013154112171
Prostate4750194801315989146186220270302353
Health6242098013169122171193226284
Index932209801312381140193241
for1197209801312986118
Predicting1339209801315586137198219268304326384443
Prostate1806209801315586142182217266299350
Cancer21802098013162112170218269301
Eur25192098013151106138
Urol2681209801316999156179
2015;28842098013154105153198213
68:31212098013153107125
1393270209801315398148
39.6242246013356110129
NCCN7762246013374137197268
Clinical1067224601336590115175200249302327
Practice1417224601336094147196235259308362
Guidelines18022246013372133158220275300325386441484
in2309224601332787
Oncology,24192246013377138187246272332394446463
2017.29062246013357112163210222
Prostate3151224801315687143183218267300351
Cancer35262248013163113171220270302
Early38522248013152102133156204
Detection40802248013173126159210260296318376434
[online]4538224801313185144166187245298323
201849022248013155106154200
[cit62423980131297496129
2-4-2021]773239801315484140174221272322369391
Dostupné11882398013171130170205263322381434
z:1646239801314464
wwwnccn17342398013180162244318366413471
org2223239801315991149
40.6242546013356114136
Nordström7832546013376137172234277313349408500
T,1306254601335974
Vickers1404254601336591140191244280324
A,1751254601337196
Assel18702546013371116158213239
M,21332546013392116
et2272254601335995
al.2391254601335682104
Comparison25192548013167123212272322353376415473531
Between30752548013159112145227279333391
the3490254801313896149
Four‑kallikrein36632548013155111169201230277327350371393438471523545602
Panel42892548013159107165218241
and45542548013154112171
Prostate4749254801315990146186221270302353
Health6242698013169122171193226284
Index932269801312381140193241
for1197269801312986118
Predicting1339269801315586137198219268304326384443
Prostate1806269801315586142182217266299350
Cancer21802698013162112170218269301
Eur25192698013151106138
Urol2681269801316999156179
2015;28842698013154105153198213
68(1):31212698013153107135183203220
139-463365269801315398148184239294
41.6242846013356105122
Bartel7702846013359113148187241267
DP.10602846013373132142
MicroRNAs:12262848013186108156188244300370432474492
genomics,17422848013160113171229319340389430449
biogenesis,2215284801316183141201254312365405427466484
mechanism,27232848013190144193251300357379418507525
and32722848013150107167
function3463284801312988145194230252310369
Cell38742848013163114137158
2004;40572848013153105160215232
116(2):4313284801315394141169220246263
281–29746002848013154104152202249301350
42.6242996013356109132
Casanova‑Salas7792996013367120162216276336388440475527580606658700
I,1503299601332952
Rubio‑Briones15792996013362122184210270306367403429489549605647
J,2250299601334465
Fernandez‑Serra23382996013357110146207260320382437484517569624659695748
A,3110299601337095
Lopez‑Guerrero32282996013355115177233280313387448503539575629665724
JA.39762996013344108133
miRNAs41332998013193115170240302344
as4501299801315493
biomarkers4619299801316486144233282314360411443484
in624314801312381
prostate729314801316092149189223273305356
cancer1109314801314999157205256288
Clin1435314801316384106163
Transl1623314801315175125183222244
Oncol18913148013174133182238261
2012;21763148013154105153197215
14(11):24153148013154100129176217237254
803–81126933148013154107157212267315356
43.6243296013356110132
Lawrie,7793296013349104183219244299320
CH,11233296013361131155
Gal13013296013369122147
S,1471329601335275
Dunlop15693296013371132192218278340
HM,19333296013369157181
et2138329601335289
al.225032960133517698
Detection23723298013169123156207256292314372431
of2827329801315684
elevated2935329801315174127175225257308369
levels3328329801312173122174197235
of3588329801315684
tumour‑associated3696329801313289178237295326355404443483541591613661693744804
microRNAs45243298013188110158190246301371434476
in5024329801312178
serum624344801314194126184273
of921344801315887
patients10323448013161110143165217275307349
with14053448013179102135193
diffuse1622344801316082111141200239292
large1938344801312372103161214
B‑cell2176344801315690141192214236
lymphoma2436344801312472162221280338428477
Br2956344801315587
J30673448013138
Haematol31293448013169118171260309341397420
2008;35743448013153105160214231
141:38293448013154100145156
672–67540093448013154104156207264314363
44.6243596013356115137
Witwer7853596013392118154237291327
KW.11353596013359155173
Circulating1332359801316284115162219241290322344402461
microRNA18173598013190111160191248303373436
biomarker2277359801316082140230279310356408439
studies:2740359801314075133192214267307324
Pitfalls3088359801315576109141191213235274
and33863598013149107166
potential35763598013160120152203261293315363385
solutions3985359801314199122179212234292351390
Clin4418359801316284106163
Chem46053598013162120173262
2015;48913598013153105152197212
61:624374801315499110
56–637583748013154106163220271
45.6243896013356110131
Lucarelli7793896013351110159212247302328353378
G,1180389601337094
Ditonno1298389601337298134193254314374
P,1695389601335868
Bettocchi17863896013359114151189248298345405430
C,2240389601336387
et2350389601335591
al.2464389601335378101
Serum25893898013150104135193282
sarcosine2895389801314191122169225265286344397
is3316389801312261
a34013898013149
risk347538980131315493138
factor3637389801312879127164220252
for3913389801312885117
progression4054389801316092149209240292332372393451509
and45873898013150107167
survival4778389801314097128181204253303325
in624404801312381
patients7294048013160110142165217275307348
with11024048013179102135193
metastatic13194048013190143176226266300350382404452
castration‑resistant1795404801314999139173205255287309367426459492543584605644678728786818
prostate2637404801316092149189223273305356
cancer3017404801314999157205256288
Future33434048013151106139197228280
Oncol36474048013174133181237260
2013;39314048013154105153198214
9(6):4169404801315382132158175
899–90743684048013154106159216269323373
46.6244197013356114137
Ferro7844197013353106142178238
M,10454197013387111
Lucarelli11804197013350110159212247301327352377
G,1581419701337094
Bruzzese1698419701335894155202251306349404
D,2125419701337292
et2240419701335490
al.2354419701335277100
Improving24784198013122111171203259308330388447
the2949419801313391145
prediction3118419801315991143203225273309331389448
of3590419801315786
pathologic37004198013160109142200258281339399421469
outcomes41934198013158116149196252341394435
in4652419801312279
patients47554198013160110142164217275307348
undergoing6244348013158116176229260318376398456515
radical1163434801313686146167216265288
prostatectomy:1475434801316496152192227276309360409445501591637656
the2156434801313795148
value23284348013153103125182235
of2587434801316291
prostate2702434801316496152192227276309360
cancer30864348013152102160208259291
antigen34014348013153111143165224277334
337604348013157
(PCA3),3841434801313286148214268292308
prostate4173434801316496153193227277309360
health45574348013163116164186219277
index4858434801312784144196244
(phi)624449801312989148170197
and8464498013149107167
sarcosine1037449801314191122169225265286344397
Anticancer14754498013164122154176225274332381432463
Res19624498013156109149
2015;21354498013154105153198212
35(2):23724498013153103129180206223
1017–102326194498013153101148192241287334384436
47.6244647013356108119
Mihelich7674647013385110171226252276325385
BL,11764647013356108131
Maranville13304647013385139174227287338363388413468
JC,18224647013337101125
Nolley19704647013369130156181236287
R,2280464701335681
et2384464701335288
al.249546470133507598
Elevated2617464901314870122171221253304364
serummicroRNA3005464901313891122181270380402450482538594664726
levels3756464901311972121173195234
associate4014464901314786126184234256304336387
with4425464901317699132190
absence46394649013146106146199257306357
of5020464901315583
high‑grade624479901315981140197231293324374433486
prostate1134479901316193150190224274306357
cancer1515479901314999157205256288
in1827479901312380
a19314799013150
retrospective2005479901313384117149206246305359408444467516568
cohort25974799013149105163222254291
PLoS29314799013155102158207
ONE31624799013174143194
2015;33994799013153105152197212
10:36354799013154101120
e012424537794799013153107155199247296344394
48.6244947013356114137
Fradet785494701335891144206261297
Y,1105494701336580
Saad12094947013359112164226
F,1459494701335870
Aprikian15534947013372134170195246273325386
A,1962494701337297
et2082494701336197
al.2202494701335984106
Upm3,23334949013174133223275292
a26494949013155
new27284949013165118196
molecular29484949013196154177230279337359408439
urine3411494901316495118175228
test3663494901314091131165
for3853494901313491123
the4000494901313997151
detection41754949013165118151202251287310367426
of4625494901316492
prostate4741494901316698155195229279311362
cancer624509901314999157205256287
Urology950509901316899156179237297346
2004;13205099013153105160215232
64:15765099013154109126
311–31517265099013154100141190239285330
49.6245246013356110129
Bettegowda7765246013355110146184238299359438499551
C,1350524601336083
Sausen14565246013351103163205259320
M,17995246013384108
Leary19305246013348102154189243
RJ,2196524601335699120
et2339524601335187
al.244952460133497496
Detection25695248013167120153204253289310368426
of3018524801315583
circulating312552480131456697144200222271302324381440
tumor3589524801313087176234265
DNA38785248013167136199
in4100524801311977
early4200524801315097128151198
–44225248013151
and44975248013146103162
late‑stage468352480131196899150185225259308367420
human6245398013159116205254312
malignancies9605398013190139161182241299348406454476528569
Sci15725398013151100122
Transl1718539801315176126184223245
Med19875398013186139199
2014;22105398013154105153200216
6(224):2450539801315482133186234259276
224ra2427505398013153106154185235288335
50.6245546013356111133
de7805546013369124
Bono9275546013367127188248
JS,11995546013347100123
Scher13455546013361110170225261
HI,16295546013379105128
Montgomery17805546013395156217252312372464519555610
RB,24135546013366126148
et2585554601336198
al.2706554601336085108
Circulating2837554801317092123170227249298330352410469
tumor3330554801314199188246278
cells36325548013156107129151190
predict38465548013168100151212233282318
survival41885548013148104136188211261310333
benefit45455548013167121179232258285318
from4887554801313669125215
treatment624569801313466117165197287340398430
in1078569801312380
metastatic11825698013191144177226266301350382405453
castration‑resistant1659569801314999138173205255287309367425459491543583604643678727785817
prostate2500569801316193149189224274306357
cancer2881569801314999156205256287
Clin3206569801316385106164
Cancer33945698013163113170219270301
Res37195698013156109149
2008;38925698013154105160214231
14:41485698013153100117
6302–630942895698013154105157206258315366418472
51.6245846013356107124
Punnoose7725846013356115175235295356399454
EA,12495846013352120145
Ferraldeschi14175846013351105140176229255316371414463524549
R,1989584601335681
Szafer-Glusman2094584601335198152184238274304379405465508598651711
E,2829584601335174
et2926584601335389
al.303858460133517699
Pten3160584801315388139197
loss3381584801312179119158
in3564584801312077
circulating366658480131466899146203225274306328386445
tumour4135584801313189178236294326
cells4485584801314697120141180
correlates46895848013147103135167219241290322373413
with6245998013179102135193
pten841599801316294145203
loss1068599801312482122162
in1254599801312381
fresh1359599801312962114154211
tumour1595599801313492181239297328
tissue194759980131355796136192245
from2216599801312962119208
castration-resistant24485998013150100139174206256288310368426459492544584605644679728786818
prostate3290599801316193150190224274306357
cancer3671599801315099157206257288
patients39835998013161111143165218276308349
Br4376599801315688
J44885998013138
Cancer45505998013163113171219270302
2015;48905998013154105153198213
113:624614801315494139155
1225–1233803614801315398151204259305350402452